You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MSLN

Showing 1 - 24 of 24
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor Trial in Beijing (aPD1-MSLN-CAR T Cells)

Not yet recruiting
  • Advanced Solid Tumor
  • αPD1-MSLN-CAR T Cells
  • Beijing, China
    National Cancer Center Cancer Hospital Chinese Academy of Medica
Jul 13, 2023

Advanced or Metastatic Solid Tumors Trial in Beijing (CD40 ligand expressing MSLN-CAR T cells, Albumin-bound paclitaxel,

Recruiting
  • Advanced or Metastatic Solid Tumors
  • CD40 ligand expressing MSLN-CAR T cells
  • +2 more
  • Beijing, Beijing, China
    Kaichao Feng
Jan 19, 2023

Solid Tumor Trial in Shanghai (aPD1-MSLN-CAR T cells)

Recruiting
  • Solid Tumor
  • αPD1-MSLN-CAR T cells
  • Shanghai, Shanghai, China
    Shanghai Mengchao Cancer Hospital
Oct 24, 2022

Safety and Efficacy of TCR-like CAR-T Trial in Nanjing (TCR-like CAR-T)

Recruiting
  • Safety and Efficacy of TCR-like CAR-T
  • TCR-like CAR-T
  • Nanjing, Jiangsu, China
    Zhongda hospital
Jul 26, 2023

Trial (MSLN STAR-T cells)

Not yet recruiting
    • MSLN STAR-T cells
    • (no location specified)
    Apr 22, 2022

    Mesothelin-positive Advanced Malignant Solid Tumors Trial (Anti-mesothelin CAR-T cells)

    Not yet recruiting
    • Mesothelin-positive Advanced Malignant Solid Tumors
    • Anti-mesothelin CAR-T cells
    • (no location specified)
    Mar 13, 2023

    Pancreatic Cancer Trial in Shatin (MSLN CART)

    Not yet recruiting
    • Pancreatic Cancer
    • MSLN CART
    • Shatin, N.t., Hong Kong
      Endoscopy Centre, Prince of Wales Hospital
    Sep 19, 2023

    Colorectal Cancer Trial (CAR T cells)

    Not yet recruiting
    • Colorectal Cancer
    • CAR T cells
    • (no location specified)
    Oct 11, 2021

    Cancer Trial in Wuhan (RD133)

    Recruiting
    • Cancer
    • Wuhan, Hubei, China
      Tongji Hospital of Tongji Medical College, Huazhong University o
    Apr 26, 2022

    Epithelial Ovarian Cancer Trial in Shanghai (LCAR-M23 cells)

    Terminated
    • Epithelial Ovarian Cancer
    • LCAR-M23 cells
    • Shanghai, Shanghai, China
      Shanghai East Hospital
    Aug 15, 2022

    Solid Tumor Trial in Nanjing (RD133)

    Recruiting
    • Solid Tumor
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital with Nanjing Medical University
    Dec 8, 2021

    Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

    Not yet recruiting
    • Solid Tumor, Adult
    • +19 more
    • A2B694
    • xT CDx with HLA-LOH Assay
    • Duarte, California
    • +9 more
    Sep 22, 2023

    Malignant Pleural Mesotheliomas (Mpm), Malignant Pleural Effusions (Mpe), Epithelial Tumors, Malignant Trial run by the National

    Not yet recruiting
    • Malignant Pleural Mesotheliomas (Mpm)
    • +4 more
    • Cytoreductive surgery
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Colorectal Cancer, Ovarian Cancer Trial in Shanghai (aPD1-MSLN-CAR T cells)

    Unknown status
    • Colorectal Cancer
    • Ovarian Cancer
    • αPD1-MSLN-CAR T cells
    • Shanghai, Shanghai, China
      Shanghai Tenth people's Hospital
    Aug 5, 2020

    Non-small-cell Lung Cancer, Mesothelioma Trial in Wuhan (aPD1-MSLN-CAR T cells)

    Recruiting
    • Non-small-cell Lung Cancer
    • Mesothelioma
    • αPD1-MSLN-CAR T cells
    • Wuhan, Hubei, China
      Union Hospital affiliated to Tongji Medical College of Huazhong
    Jul 27, 2020

    Carcinoma, Ovarian Epithelial, Ovarian Tumors, Fallopian Tube Tumors Trial in Iowa City (AB-1015)

    Recruiting
    • Carcinoma, Ovarian Epithelial
    • +8 more
    • AB-1015
    • Iowa City, Iowa
      U. of Iowa Health Care
    Jan 30, 2023

    Mesothelin Positive, Stage III NSCLC AJCC v7, Stage IIIA NSCLC AJCC v7 Trial in Phoenix, Jacksonville, Rochester (Anetumab

    Terminated
    Has Results
    • Mesothelin Positive
    • +4 more
    • Anetumab Ravtansine
    • +2 more
    • Phoenix, Arizona
    • +2 more
    Jan 5, 2023

    Solid Tumor Trial (UCLM802 Cell Injection)

    Not yet recruiting
    • Solid Tumor
    • UCLM802 Cell Injection
    • (no location specified)
    Mar 7, 2023

    Mesothelin-positive Advanced Malignant Solid Tumors Trial in Hangzhou (UCLM802 Cell Injection (Anti-mesothelin CAR-T cells))

    Recruiting
    • Mesothelin-positive Advanced Malignant Solid Tumors
    • UCLM802 Cell Injection (Anti-mesothelin CAR-T cells)
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital Zhejiang University School of Medi
    May 11, 2023

    Public AttitudesTowards SMA and DMD Awareness, Newborn and

    Not yet recruiting
    • Spinal Muscular Atrophy
    • +2 more
    • Questionnaire
    • (no location specified)
    Nov 8, 2021

    Pancreatic Cancer, Gut Microbiota, CAR-T Trial in Harbin

    Recruiting
    • Pancreatic Cancer
    • +2 more
      • Harbin, Heilongjiang, China
        The first affiliated hospital of Harbin medical university
      Dec 16, 2019

      Tumors With Mesothelin Expression, Epithelioid Mesothelioma, Cholangiocarcinoma, Extrahepatic Trial run by the NCI (LMB-100,

      Active, not recruiting
      Has Results
      • Neoplasms With Mesothelin Expression
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 18, 2022

      Epithelial Ovarian Cancer, Triple Negative Breast Cancer, Non-squamous Non-small-cell Lung Cancer Trial in Paris, Rennes, Milano

      Recruiting
      • Epithelial Ovarian Cancer
      • +2 more
      • NI-1801
      • Paris, France
      • +4 more
      Nov 4, 2022

      Cancer Trial in Worldwide (RO6927005, gemcitabine, nab-paclitaxel)

      Terminated
      • Cancer
      • Bethesda, Maryland
      • +5 more
      Jul 22, 2016